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INTRODUCTION
Stroke is generally characterized by the sudden loss of blood circulation in the brain, resulting in a corresponding loss of neurologic function, complications, and death. This can be due to a lack of blood fl ow caused by blockage or a hemorrhage (Sims and Muyderman, 2010) . Astrocytes, the principal housekeeping cells of the nervous system, are not merely supportive of neurons but also perform crucial brain functions, including maintenance of ionic homeostasis, neovascularization, synaptogenesis, neurogenesis, prevention of excitotoxicity, and free radical scavenging (Raghubir, 2008) . Thus, protection and maintenance of astrocyte function during focal stroke may be more important than that of neurons. However, astrocytes may negatively affect the balance of life and death in certain situations. After some ischemic insults, such as permanent MCAO and transient ischemia, reactive astrocytes express infl ammatory mediators that may contribute to growth of a stroke (Asano et al., 2005) Several studies have reported that inhibiting infl ammatory processes such as production of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) reduces delayed increases in stroke volume in animal models. Thus, infl ammatory signaling cascades are a target of translational research on stroke Iadecola and Alexander, 2001; Lakhan et al., 2009) . Many pro-infl ammation enzymes such as iNOS, COXs and xanthine oxidase participate in oxidative injury during cerebral ischemia (Chan, 2001) . iNOS is found in astrocytes, microglia, and macrophages where it is a major source of reactive oxygen species (ROS) generation www.biomolther.org (Vaughan and Delanty, 1999) .
The rose (genus Rosa), allied to its use as a source of aromatic oils for the perfume industry, has been an alternative model for pharmaceutical candidates to treat diabetes mellitus, pain, and infl ammatory diseases (Cho et al., 2003; Ng et al., 2005; Jeon et al., 2009) . Previously, we reported that the hexane fraction from white rose fl owers, which may contain high amounts of gallic acid and volatiles, displayed a broad range of anti-oxidant, anti-microbial, anti-allergic and anti-infl ammatory effects Joo et al., 2010; . In the present study, the neuroprotective effects of a butanol fraction of a white rose petal extract (WRPE-BF) were evaluated using the MCAO technique, as an animal model of human ischemic stroke, by analyzing anti-oxidative and antiinfl ammatory profi les as well as morphological and neurobehavioral changes in rats.
MATERIALS AND METHODS

Fractionation of the white rose petal extract
Fresh white rose petals (R. hybrida) were collected in Jincheon, Republic of Korea in May 2010 and freeze-dried. A voucher specimen (KWNU80941) was authenticated by Dr. Jang (Gangneung-Wonju National University, Republic of Korea) and deposited at the herbarium of Kangwon National University, Republic of Korea. The dried petals were ground in a rotor mill, and the pulverized petals were sterilized using a 70% ethanol spray, followed by drying at 70°C for 48 h and storage at 4°C before use. The fi nely-ground powder was extracted with 80% ethanol at room temperature for 24 h. The ratio of powder to solvent was 1:20 (w/v). Total ethanol extracts were fi ltered through Watmann No. 1 fi lter paper (Watmann International Ltd., Maidstone, UK). These fi ltrates were collected and evaporated at 50°C and freeze-dried. Then, fractionation was sequentially performed using n-hexane, nbutanol and water (Fig. 1) . Among three resulting fractions, the butanol fraction was concentrated under vacuum at 50°C and completely dried for further study.
Animals
Six-week-old male Sprague-Dawley rats, weighing 180-220 g, were purchased from Daehan Biolink (Chungbuk, Republic of Korea). They were housed in an environmentally-controlled room at constant temperature (23 ± 3°C) and relative humidity (50 ± 10%) and exposed to a 12 h light/dark cycle. The animals were fed a standard rodent chow and purifi ed water ad libitum. All experimental procedures were carried out in accordance with the Standard Operating Procedures of the Laboratory Animal Center, Chungbuk National University, Korea, and this protocol was approved by the Institutional Animal Care and Use Committee (Approval #: CBNUA-341-11-01).
Gas chromatography-mass spectrometry (GC-MS)
Analysis of the WRPE-BF was performed on an Agilent Technologies 5975C GC/MS instrument equipped with a CTC CombiPAL autosampler system (Palo Alto, CA, USA). Chromatographic separation of the WRPE-BF was carried out in helium carrier gas on an HP-5 column (Agilent Technologies, 250 μm×0.25 μm×30 m). A 10 μl volume of sample was injected into a split injector operated in split mode using a 5:1 split ratio with a 5 ml/min split fl ow and 1 ml/min column fl ow. The injector temperature was held at 250°C, and the transfer line was held at 250°C. The GC oven was held at 50°C for 5 min, ramped at 3°C/min to 280°C, with a hold for 5 min. The ion source temperature was 250°C with an electron impact ionization energy of -70 V. Following a 4 min delay, data were collected from 35-250 m/z using a detector voltage of 1059 V. Components were identifi ed based on a comparison of their relative retention times and mass spectra with those of standards from the Wiley7N library data of the GC-MS system.
Treatment
After a 1-week acclimation to the laboratory environment, the rats were divided into four groups: sham operation, vehicle-treated MCAO, 10 mg/kg WRPE-BF-treated MCAO and 32 mg/kg WRPE-BF-treated MCAO (n=15/group). The animals were orally administered the WRPE-BF at dose levels of 10 or 32 mg/kg/day or its vehicle (purifi ed water) for 2 weeks and then subjected to MCAO 30 min after the last treatment.
MCAO surgery
Silcone-coated thread was prepared based on the method described previously (Schmid-Elsaesser et al., 1998) . Briefl y, polyethylene tubing (Intramedic, Batavia, IL, USA), with a nominal internal diameter of 0.38 mm, was fi lled with silicone (Koreseal, Busan, Republic of Korea). A 3/0 monofi lament nylon suture (Ailee, Busan, Republic of Korea) was inserted 5 mm into one end of the polyethylene tubing . The tubing and encased silicone were cut with a razor blade at a point 0.5 mm beyond the tip of the suture after 24 h. Immediately prior to surgery, the suture was removed from the tubing, leaving a uniform coating of silicone bonded to the distal 5 mm of the artery. Focal cerebral ischemia was produced as described previously with a slight modifi cation (Longa et al., 1989; Choi et al., 2012; Park et al., 2012) . Briefl y, rats were anesthetized with 5% isofl urane in 25% O 2 /75% N 2 for induction and maintained with 1.5-2% isofl urane. A midline incision was made on the ventral side of the neck, exposing the left common carotid artery, which was freed from surrounding tissues. The external carotid artery was ligated and dissected. The silicone-coated thread was introduced through the external carotid artery and advanced 18 mm via the internal carotid artery up to the origin of the middle cerebral artery. After occlusion was achieved, the silicone-coated thread was secured in place by ligature, and the incision was sutured. Only the fi lament was introduced into the external carotid artery but was not advanced in the sham-operated group. The rats were anaesthetized with isofl urane via a nose cone during the operation, and rectal body temperature was maintained at 37 °C using a temperature-regulated heating pad. The silicone thread was removed for reperfusion after a 2 h occlusion.
2,3,5-Triphenyltetrazolium chloride (TTC) staining
Rat brains were carefully dissected 24 h after MACO, and 2-mm coronal sections were cut in a pre-cooled stainless matrix. Individual sections were placed in 24-well plates and incubated in 2% TTC stain in saline for 15 min at 37°C. Gentle stirring of the plates ensured even staining exposure. Excess TTC was drained off, and slices were fi xed in 10% neutral buffered formalin. The area of infarction of each section was determined using a computerized image analysis system. Total lesion volume was calculated by summing up the infarction areas in each section and multiplying by slice thickness.
Measurement of lipid peroxidation
Lipid peroxidation was measured by determining the formation of malondialdehyde (MDA)-based ions in the presence of thiobarbituric acid-reactive substances (TBARS) in the brain (Ohkawa et al., 1979; Callaway et al., 1998) . Briefl y, rat brains were dissected immediately after intracardial perfusion with cold saline. Brain tissue was homogenized in 10 volumes of cold phosphate-buffered saline (PBS) and centrifuged at 4,000 rpm for 5 min to obtain the supernatant. Sodium dodecyl sulfate (SDS; 500 μl of 8.1% w/v solution) and 1 ml of 20% acetic acid (pH 3.5) were added to the brain homogenate and centrifuged. Aliquots of the clear supernatant were mixed with an equal volume of thiobarbituric acid solution (0.8% w/v) and Table 1 . The presence of pyrogallol in WRPE-BF was identifi ed by the same retention time (31 min) and a single pyrogallol peak was referenced as shown in B. 
Fig. 2. Gas chromatography-mass spectrometry (GC-MS) chromatogram (A). Peaks were analyzed based on the GC-MS library listed in
Determination of NO in cerebrospinal fl uid
Cerebrospinal fl uid (CSF) was collected carefully so as not to be contaminated with blood by puncturing the cervical cisterna membrane after sacrifi cing the rats with ether anesthesia. Nitrite in CSF was measured as a fi nal product of NO generation using a Griess reagent system at 540 nm (Promega, Madison, WI, USA).
Glial fi brillary acidic protein (GFAP) immunohistochemistry
For immunohistochemical staining for GFAP, formalin-fi xed paraffi n-embedded brain sections (4 μm in thickness) were rinsed in PBS and treated with 3% hydrogen peroxide for 15 min to block endogenous peroxidase activity. After washing with PBS and blocking with 3% bovine serum albumin (BSA) for 10 min, the sections were incubated overnight at 4°C with antibodies specifi c to GFAP (Dako, Glostrup, Denmark) and then with biotinylated goat anti-rabbit IgG (Vector Laboratories Inc, Burlingame, CA, USA) for 1 h at room temperature, followed by avidin-conjugated peroxidase complex for 30 min at room temperature. The peroxidase reaction was visualized using 3,3′-diaminobenzidine tetrahydrochloride (0.02%) as a chromogen and counterstained with hematoxylin for 4 min.
The sections were rinsed, mounted on poly-L-lysine-coated slides, dehydrated, and cover-slipped for light microscopy and photography.
Western blot analysis
Brain tissues were homogenized in 10 volumes of RIPA buffer containing protease inhibitors (Roche Diagnostics GmbH, Mannheim, Germany), and the homogenates were separated by 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis. Then, proteins were transferred onto polyvinylidene fl uoride membranes and the membranes were blocked with 5% skim milk in Tris-buffered saline solution containing 0.1% Tween-20. The membranes were then immunoblotted with primary antibodies, anti-COX-2 (Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-iNOS (Santa Cruz Biotechnology), anti-GFAP and anti-β-actin (Santa Cruz Biotechnology), followed by incubation with horseradish peroxidase-conjugated anti-rabbit or anti-mouse secondary antibodies (Stressgen Biotechnologies Inc, San Diego, CA, USA). Blots were developed using an ECL solution (Thermo Scientifi c, Rockford, IL, USA).
Measurement of neurobehavioral functions
Motor coordination and balance were evaluated using a rota-rod test system (Panlab Technology, Barcelona, Spain). Rats were placed on the rotating rod at an accelerating speed from 4 to 40 rpm over a period of 5 min, and the time of falling off the rod was recorded. Spontaneous locomotor activity was evaluated using a video tracking system (Smart v2.5; Panlab Technology), connected to a CCTV monitor. Rats were placed in a quiet chamber (50×50×30 cm), and each time of the movement types; i.e., resting, slow-moving, and fast-moving, was recorded for 2 min following 15-sec adaptation time. Animals were tested three times during one session and the ratio of movement types was analyzed.
Statistical analysis
Statistical comparisons between the groups were performed using one-way analysis of variance followed by Dunnet's posthoc test, which were performed using SPSS software v.13 (SPSS Inc., Chicago, IL, USA). Statistical signifi cance was set a priori at p<0.05.
RESULTS
The GC-MS analysis showed that the WRPE-BF contained various components with different retention times ( Fig. 2A) . GC-MS identifi ed three major components (Table 1) , including 2,3-dihydro-3,5-dihydroxy-6-methyl-4H-pyran-4-one (4.95%), 5-(hydroxymethyl)-2-furancarboxaldehyde (23.73%) and 1,2,3-benzenetriol (pyrogallol) (43.60%) which constituted 72.30% of the total peak area. Pyrogallol, a major substance, was confi rmed by analyzing the results with commercial pyrogallol (cat. no. P-0381, Sigma-Aldrich Co., St. Louis, MO, USA) (Fig. 2B) .
Brain injury was evaluated by quantifying the total infarction area in rat brain tissues 22 h after reperfusion following a 2 h occlusion. Representative TTC staining patterns of the rat brain tissues are illustrated in Fig. 3A . When pretreated with WRPE-BF, infarction volume was signifi cantly reduced in a dose-dependent manner to 26.6% and 7.3% with 10 and 32 mg/kg WRPE-BF, respectively, compared to the control group (vehicle) (Fig. 3B) . WRPE-BF also attenuated brain edema, particularly to the near-normal level at 32 mg/kg (Fig. 3C) .
The elevated level of MDA in the MCAO brains (vehicle, 81.0 nmol/g) was remarkably decreased by pretreatment with WRPE-BF in a dose-dependent manner to 61.4 and 50.6 nmol/g at 10 and 32 mg/kg, respectively (Fig. 4A) . Coincidentally, NO production in CSF in the MCAO brains (vehicle, 56.7 μmol/L) was signifi cantly suppressed to 41.5 and 32.5 μmol/L when pretreated with 10 and 32 mg/kg of WRPE-BF, respectively.
The number of activated astrocytes increased greatly in the subventricular zone and striatum of MCAO rats, although the response was much greater in the subventricular zone than that in striatum (Fig. 5A) . However, astrocytic activation was inhibited signifi cantly by pretreatment with WRPE-BF (32 mg/ kg) to the normal level in both the subventricular zone (Fig.  5B) and striatum (Fig. 5C) .
Moreover, the production of infl ammatory mediators, iNOS and COX-2 was greatly increased in MCAO rats. Moreover, GFAP was also increased similar to the level of iNOS and COX-2. However, Western blot profi les represented the elevated infl ammatory mediators were remarkably attenuated by pretreatment with WRPE-BF in a dose-dependent manner, although GFAP expression was more responsive to the low dose (Fig. 6) .
Interestingly, as shown in Fig. 7A , the decreased latency time in rota-rod performance of MCAO rats was signifi cantly recovered by pretreatment with WRPE-BF in a dose-dependent manner. Moreover, locomotor activity tests for the assessment of global activity (resting, slow-moving and fastmoving times) revealed that the decreased physical activity of Fig. 4 . Effects of white rose petal extract-butanol fraction (WRPE-BF) on the levels of malondialdehyde (MDA) and nitric oxide (NO) increased by middle cerebral artery occlusion (MCAO). MDA in brain homogenate (A) and NO in CSF (B) from rats subjected to 2-h MCAO followed by 22-h reperfusion were analyzed.
a Significantly different from sham control (p<0.05).
b Signifi cantly different from vehicle control (p<0.05). www.biomolther.org the MCAO rats was remarkably restored by pretreatment with WRPE-BF in a dose-dependent manner, exhibiting reduced resting times and increased moving times (Fig. 7B) .
DISCUSSION
Many efforts to screen neuroprotecive materials using the MCAO animal model have been made, because MCAO recapitulates the biochemical and pathological features of human stroke, such as oxidative stressors and infl ammatory responses (Pan et al., 2009) . Functional behavioral defi cits are common neurological sequelae in patients with brain injuries and in animal models of cerebral ischemia. Thus, behavioral parameters are useful measures of functional defi cits following experimental focal cerebral ischemia, and the degree of sensorimotor dysfunction is an important indicator of injury severity (Rogers and Hunter, 1997) .
Previously, we reported that neurobehavioral defi cits correlated with cerebral infarction volume in MCAO rats and that reperfusion facilitated the brain injury triggered by ischemia Park et al., 2012) . The WRPE-BF treatment not only reduced infarct size and edema but also improved behavioral defi cits, indicating a good relationship between neuroprotection and functional recovery. ROS can be used to assess cellular damage and death during cerebral ischemia and reperfusion as a biochemical mechanism of ischemic brain injury (Chan, 2001; Clark et al., 2001; Margaill et al., 2005) , because generation and release of excessive ROS during reperfusion plays a major role in brain injury (Chan, 1996; Choi et al., 2012) . The elevated free radicals that occur during ischemic stroke could increase the levels of lipid peroxidation products including TBARS (MDA) and lipid peroxides in the plasma, blood, and brain tissues (Pan et al., 2009; Thaakur and Sravanthi, 2010) . In the present study, MDA levels increased by 75% in MCAO brains, indicating severe tissue injuries was markedly decreased when pretreated with WRPE-BF.
NO is involved in brain injury development during stroke as well as neurogenesis in the adult hippocampus (Mohammadi et al., 2012) . Notably, iNOS is implicated as an important mediator of oxidative and infl ammatory responses during ischemia-reperfusion. Astrocytes are the most abundant cells in the brain and serve as an important source of infl ammatory mediators during the course of neuroinfl ammation (MojsilovicPetrovic et al., 2007) . Activation of the iNOS-NO pathway occurred in parallel with the increased number of activated astrocytes, which were confi rmed by up-regulation of GFAP production, while activation of astrocytes was effectively suppressed by WRPE-BF.
COX-2 is constitutively expressed in excitatory neurons, upregulated in many organs by a wide variety of stimuli, and plays an important role in the COX-2-PG infl ammatory stream besides the iNOS-NO pathway (Collaço-Moraes et al., 1996; Nogawa et al., 1997) . Moreover, COX-2 is upregulated after cerebral ischemia in 12-24 h, and induces a deleterious role during cerebral ischemia in collaboration with NO (Nogawa et al., 1998) . Activated astrocytes are also an important source of infl ammatory COX-2 in addition to iNOS (Mojsilovic-Petrovic et al., 2007) . Our study revealed that iNOS and COX-2 expression were downregulated by WRPE-BF, suggesting its pivotal role for anti-infl ammatory activity.
It is well known that activation of astrocytes is a result of brain injury. Thus, the increased expression of GFAP, an astrocyte cytoskeletal protein, is a quantitative marker of neural tissue injury . As predicted, WRPE-BF decreased the number of activated astrocytes in the subventricular zone and striatum in parallel with decreased GFAP expression and infarction area. Such a neuroprotective effect of WRPE-BF is inferred from the anti-oxidant and anti-infl ammatory activities of pyrogallol, a major component, which belongs to reducing species having known to strongly scavenge free radicals and inhibit infl ammatory mediators (Kondo et al., 1999; Nicolis et al., 2008) . Taken together, the WRPE-BF exerted neuroprotective effects in a MCAO model of stroke by suppressing astrocyte activation and inhibiting infl ammatory and oxidative indices. Although the active ingredients in WRPE-BF remain to be clarifi ed, WRPE-BF improved neurobehavioral functions via neuroprotective activity. Therefore, we concluded that WRPE-BF may be a good candidate for neuroprotective agents, which is advantageous for pharmaceutical applications for ischemic stroke.
